Add BrightSurf on Google Email

A skin biopsy to detect a rare neurodegenerative disease

Researchers at UNIGE successfully determined the structure of abnormal protein deposits from a skin biopsy, paving the way for earlier diagnosis and potentially more accessible treatment options. The study's breakthrough opens up new avenues for studying neurodegenerative diseases, including Alzheimer's and Parkinson's.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateJan 26, 2026

Brain network disorders study provides insights into the role of molecular chaperones in neurodegenerative diseases

A study reviews decades of research on Hsp70's role in neurodegenerative diseases, highlighting its protective effects and potential therapeutic value. The review reveals that different Hsp70 isoforms interact with co-chaperones and cellular pathways to determine protein clearance.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateJan 22, 2026

Researchers study whether intentionally manipulating blood carbon dioxide levels might enhance brain health

A team of researchers found that intentionally raising and lowering blood CO2 levels through rhythmic exposure or controlled breathing may boost the glymphatic system's effectiveness. This approach could preserve brain function, improve cognition, and reduce cognitive decline in Parkinson's patients.

Disappointment alters brain chemistry and behavior

A mouse study by Okinawa Institute of Science and Technology researchers has found that acetylcholine release is essential for breaking habits and enabling new choices to be made. The study's findings may help understand diseases such as Parkinson's disease, addiction, and obsessive-compulsive disorder.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalNature Communications·TypeExperimental study·DateDec 17, 2025

Chinese Neurosurgical Journal study explores the role of a combined therapy in Parkinson’s disease treatment

Researchers investigated a combination of stem cell therapy and BDNF enhancement to treat Parkinson's disease. The strategy aims to promote neuroregeneration and functional recovery by introducing progenitor cells genetically matched to the donors, while upregulating BDNF to mitigate neuronal loss and enhance motor function.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateDec 16, 2025

Exercise might help improve mobility during aging

A new study found that aerobic exercise can increase dopamine release and improve motor performance in middle-aged mice, suggesting a potential link to improved mobility and reduced symptoms of Parkinson's disease. The research team plans to repeat the study in genetically engineered mice models for neurodegenerative disorders.

SourceNYU Langone Health / NYU Grossman School of Medicine·Journalnpj Parkinson s Disease·TypeExperimental study·DateDec 9, 2025

Role of ubiquilin-2 liquid droplets in α-synuclein aggregation

Studies have confirmed that liquid droplets formed by ubiquilin-2 (UBQLN2) facilitate the aggregation and fibril formation of α-synuclein protein. Researchers also discovered a compound that interacts with UBQLN2, preventing its self-association and liquid droplet formation, which may lead to new treatments for neurodegenerative diseases.

SourceJuntendo University Research Promotion Center·JournalThe EMBO Journal·TypeExperimental study·DateNov 26, 2025

Untreated sleep apnea raises risk of Parkinson’s, study finds

A new study examining millions of electronic health records suggests a strong link between untreated obstructive sleep apnea and an increased risk of developing Parkinson's disease. Researchers found that those with untreated sleep apnea were nearly twice as likely to develop Parkinson's as those who treated it with CPAP.

SourceOregon Health & Science University·JournalJAMA Neurology·TypeData/statistical analysis·DateNov 24, 2025

Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders

Researchers at UGA engineered a live bacterium to deliver Levodopa steadily from the gut to the brain, alleviating motor deficits in models of Parkinson's disease. This breakthrough could lead to fewer pills, steadier symptom control, and better quality of life for patients.

SourceUniversity of Georgia, College of Veterinary Medicine·JournalCell Host & Microbe·TypeRandomized controlled/clinical trial·DateNov 13, 2025

UT Health San Antonio Center for Brain Health celebrates ‘a new era of hope, healing and discovery’ with ribbon-cutting

The UT Health San Antonio Center for Brain Health is a $100 million facility that brings together clinical care, diagnostics and research under one roof. The center will redefine treatment of conditions including Alzheimer's, dementia, stroke and Parkinson's with multidisciplinary care teams.

Nonsurgical treatment shows promise for targeted seizure control

A nonsurgical approach has been demonstrated to quiet a specific brain circuit in an animal model by delivering engineered gene therapy only to the targeted region. The method uses low-intensity focused ultrasound to open the blood-brain barrier, allowing precise control over brain activity without impacting off-target areas.

SourceRice University·JournalACS Chemical Neuroscience·TypeExperimental study·DateNov 11, 2025

USC researchers use AI to uncover genetic blueprint of the brain’s largest communication bridge

The study identified dozens of genetic regions that influence the size and thickness of the corpus callosum and its subregions. The research team created an AI-powered tool that finds and measures the corpus callosum in brain MRI scans automatically, allowing for unprecedented analysis of brain structure at scale and precision.

SourceKeck School of Medicine of USC·JournalNature Communications·TypeImaging analysis·DateNov 4, 2025

Personalised care key to easing pain for people with Parkinson’s

New research from the University of South Australia highlights the need for personalized, multidisciplinary and empathetic care for people with Parkinson's disease. Researchers found that gaps in support lead many individuals to rely on trial-and-error approaches to manage their pain, resulting in reduced quality of life.

SourceUniversity of South Australia·JournalJournal of Multidisciplinary Healthcare·TypeCase study·DateNov 3, 2025

Barrow study: Ambient TCE exposure suggests link to Parkinson’s disease risk nationwide

A Barrow Neurological Institute study found a positive association between ambient trichloroethylene (TCE) and Parkinson's disease risk. The researchers identified a potential link between TCE exposure and an increased risk of Parkinson's disease, particularly in individuals living near facilities emitting the chemical.

SourceDignity Health Arizona·JournalNeurology·TypeObservational study·DateOct 1, 2025

Tiny treatment system helps fight back against neuroinflammation in the brain

A new study published in Biomaterials has developed a tiny, bioengineered system to deliver anti-inflammatory proteins to specific targets in the brain. The AstroCapsules, which are 300 micrometers in diameter, were confirmed to function when implanted into the brain and reduced neuroinflammation by measuring inflammatory biomarkers.

SourceHouston Methodist·JournalBiomaterials·TypeExperimental study·DateSep 25, 2025

Tiny worms reveal big secrets about memory

Researchers have found that tiny worms can help understand how memories fade, with dopamine playing a major role. Without dopamine, the worms held onto memories longer than usual, revealing that forgetting is a finely tuned process essential for staying focused and flexible.

SourceFlinders University·JournalJournal of Neurochemistry·TypeExperimental study·DateSep 25, 2025

Chinese Medical Journal study reviews the association between lipid metabolism and Parkinson’s disease

A Chinese Medical Journal study reviews the association between lipid metabolism and Parkinson’s disease. The research highlights how lipid disruptions contribute to α-Syn aggregation, mitochondrial dysfunction, and neuroinflammation, suggesting lipids as a promising therapeutic target for PD.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateSep 17, 2025